Thema: US69404D1081
PACB, US69404D1081
stocks-6377806_1920.jpg - Foto: THN
Pacific Biosciences stock trades at 2.22 euros in Berlin evening quote
Pacific Biosciences stock remained in focus for investors on Friday. The latest quote offers a fresh reference point for monitoring the shares.
ad-hoc-news.de, 30.10.26 20:21 Uhr
PACB, US69404D1081
PacBio schedules November 4 results for Pacific Biosciences ...
Revenue was USD 39.01 million in the second quarter. Pacific Biosciences stock costs EUR 2.22 on October 27, 2026 at Lang & Schwarz after market close.
ad-hoc-news.de, 27.10.26 21:54 Uhr
PACB, US69404D1081
Stephens raises target for Pacific Biosciences stock to ...
PacBio will report third-quarter results on November 4, 2026 after market close. Pacific Biosciences stock costs EUR 1.87 on October 24, 2026.
ad-hoc-news.de, 24.10.26 18:45 Uhr
PACB, US69404D1081
Barclays cuts target for Pacific Biosciences stock to USD ...
Barclays cut its target to USD 1.25 on October 7, 2026. Pacific Biosciences stock costs EUR 1.78 on October 20, 2026 at Lang & Schwarz.
ad-hoc-news.de, 20.10.26 21:38 Uhr
PACB, US69404D1081
Pacific Biosciences stock falls 11.73 percent to USD 1.73 ...
Fair value rose to USD 2.40 on October 8, 2026. Pacific Biosciences stock stood at USD 1.73 on October 16, 2026, down 11.73 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 19:52 Uhr
PACB, US69404D1081
Six brokerages set USD 1.71 target for Pacific Biosciences ...
PacBio reports third-quarter results on November 4, 2026. Pacific Biosciences stock costs EUR 1.76 on October 15, 2026 at 9:11 p.m. CEST.
ad-hoc-news.de, 15.10.26 21:18 Uhr
PACB, US69404D1081
Barclays keeps Sell rating for Pacific Biosciences stock ...
Barclays set a USD 1.25 target under Sell on October 7, 2026. Pacific Biosciences stock stands at EUR 2.43 on October 8, 2026 versus EUR 2.41.
ad-hoc-news.de, 08.10.26 11:24 Uhr
PACB, US69404D1081
Pacific Biosciences stock hits a new 52-week high
Second-quarter revenue was USD 39.00 million versus USD 39.80 million. Pacific Biosciences stock costs EUR 2.56 on October 5, 2026 after EUR 2.24.
ad-hoc-news.de, 05.10.26 22:49 Uhr
Pacific, Biosciences
Pacific Biosciences Sharpens Focus with Strategic Shift ...
Pacific Biosciences US69404D1081
boerse-global.de, 05.02.26 22:44 Uhr
Pacific, Biosciences
Pacific Biosciences Faces Extended Path to Profitability ...
